Kothapalli, US
Aparna Kothapalli, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20130209646 | EXTRUDABLE BATTER COMPOSITIONS FOR USE IN PROVIDING HIGH-FIBER FLOURLESS FOOD PRODUCTS - The invention provides an extrudable batter for use in providing a shelf-stable, ready-to-eat high-fiber food product. The batter comprises a select amount of a powdered fiber, at least one fat component chosen from an oil and a shortening, the shortening having a solid fat content of about 2% to about 30% at ambient temperature, a humectant, a sweetener, a leavening agent and water. The resultant uncooked batter is flourless and gluten-free and is extrudable in a continuous form. The ready-to-eat high-fiber food product produced by such batter contains about 5 grams or more of fiber per serving and substantially maintains, before and after being baked, a desired shape, structure and moisture content. | 08-15-2013 |
Aparna Kothapalli, West Lafayette, IN US
Patent application number | Description | Published |
---|---|---|
20100075301 | Methods for Generation of Reporter Phages and Immobilization of Active Bacteriophages on a Polymer Surface - Novel reporter bacteriophages are provided. Provided are compositions and methods that allow bacteriophages that are used for specific detection or killing of | 03-25-2010 |
20120184012 | Methods for Generation of Reporter Phages and Immobilization of Active Bacteriophages on a Polymer Surface - Novel reporter bacteriophages are provided. Provided are compositions and methods that allow bacteriophages that are used for specific detection or killing of | 07-19-2012 |
Chandrasekhar Kothapalli, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20140057311 | Device For High Throughput Investigations Of Multi-Cellular Interactions - Provided herein are microfluidic devices that can be used as a 3D bioassay, e.g., for drug screening, personalized medicine, tissue engineering, wound healing, and other applications. The device has a series of channels {e.g., small fluid channels) in a small polymer block wherein one or more of the channels can be filled with a biologically relevant gel, such as collagen, which is held in place by posts. As shown herein, when the device is plated with cells such as endothelial cells, new blood vessels grow in the gel, which is thick enough for the cells to grow in three dimensions. Other channels, e.g., fluid channels, allow drugs or biological material to be exposed to the 3D cell growth. Cells, such as endothelial cells, can be cultured and observed as they grow on the surface of a 3D gel scaffold, where e.g., rates of angiogenesis can be measured, as well as intervascularization and extravascularization of cancerous cells. | 02-27-2014 |
Deydeep Kothapalli, Chandler, AZ US
Patent application number | Description | Published |
---|---|---|
20140115723 | System and Method for Digital Media Distribution - The present invention comprises a digital media delivery system with a physical authorization device for downloading media files to a digital media player. The physical authorization device is most preferably an indicia-bearing card, containing at least one of an NFC circuit with the NFC circuit comprising a reusable media authorization code, and/or a Quick Response code with a reusable media authorization code embedded in the QR code, and/or an eye-legible version of the reusable media authorization code. By touching or tapping the indicia-bearing card on the NFC enabled media player, or scanning the QR code, or entering the eye-legible media authorization code from the authorization device into a digital media player, the reusable media authorization code is transmitted to a file server on the Internet via an application on the digital media player and one or more media files will be downloaded to the digital media player or otherwise enabled for accessing on the digital media player. Once downloaded to the digital media player or otherwise enabled, the user may access the downloaded media file(s). | 04-24-2014 |
Kumar Sesha Kothapalli, Ithaca, NY US
Patent application number | Description | Published |
---|---|---|
20090099259 | Method for regulating gene expression - The present invention is directed to a novel method for modulating the expression of one or more genes in a subject by administering an amount of DHA and ARA to the subject. | 04-16-2009 |
Madhusudanarao Kothapalli, Plainsboro, NJ US
Patent application number | Description | Published |
---|---|---|
20090169619 | CARBAMAZEPINE EXTENDED RELEASE DOSAGE FORM - Extended release pharmaceutical dosage forms of carbamazepine for oral administration to maintain a patient's blood concentration for at least a 12 hour period, methods of administering dosage forms and processes for the preparation of such dosage form. | 07-02-2009 |
Malini Kothapalli, Reston, VA US
Patent application number | Description | Published |
---|---|---|
20140006642 | SYSTEMS AND METHODS FOR AUTOMATICALLY PROVIDING WHOIS SERVICE TO TOP LEVEL DOMAINS | 01-02-2014 |
Malini Kothapalli, Centreville, VA US
Patent application number | Description | Published |
---|---|---|
20110022678 | METHOD AND SYSTEM FOR DATA LOGGING AND ANALYSIS - A method of logging internet requests includes defining a plurality of field types of interest and receiving a request from the internet including one or more fields. The method also includes determining that a first field type of a first field of the one or more fields matches one of the plurality of field types of interest and caching at least a portion of the first field in a cache. The method further includes determining that a second field type of a second field of the one or more fields matches one of the plurality of field types of interest caching at least a portion of the second field in the cache. The method includes transmitting the cache to a server, determining, a number of occurrences of a field value of at least one of the first field type or the second field type, and providing a report including the number of occurrences of the field value. | 01-27-2011 |
20140006439 | SYSTEMS AND METHODS FOR AUTOMATICALLY PROVIDING WHOIS SERVICE TO TOP LEVEL DOMAINS | 01-02-2014 |
Muralidhar Kothapalli, Chandler, AZ US
Patent application number | Description | Published |
---|---|---|
20140115723 | System and Method for Digital Media Distribution - The present invention comprises a digital media delivery system with a physical authorization device for downloading media files to a digital media player. The physical authorization device is most preferably an indicia-bearing card, containing at least one of an NFC circuit with the NFC circuit comprising a reusable media authorization code, and/or a Quick Response code with a reusable media authorization code embedded in the QR code, and/or an eye-legible version of the reusable media authorization code. By touching or tapping the indicia-bearing card on the NFC enabled media player, or scanning the QR code, or entering the eye-legible media authorization code from the authorization device into a digital media player, the reusable media authorization code is transmitted to a file server on the Internet via an application on the digital media player and one or more media files will be downloaded to the digital media player or otherwise enabled for accessing on the digital media player. Once downloaded to the digital media player or otherwise enabled, the user may access the downloaded media file(s). | 04-24-2014 |
Ravi Kothapalli, Westley Chapel, FL US
Patent application number | Description | Published |
---|---|---|
20110021375 | Sphingosine 1-Phosphate Receptor Gene, SPPR - A novel sphingosine 1-phosphate receptor gene, herein termed sppr, and its splice variants. Sppr is up-regulated in LGL and is useful, for example, in the diagnosis and treatment of certain lymphoproliferative, neurodegenerative and autoimmune diseases. | 01-27-2011 |
Ravi Kothapalli, Wesley Chapel, FL US
Patent application number | Description | Published |
---|---|---|
20080200379 | Diagnostic markers of human female infertility - The subject invention pertains to methods and reagents for the diagnosis of female infertility, prognostic indicators for female infertility, compounds for the treatment of female infertility, compounds and methods for contraception. Methods and compounds are based on the levels of ebaf in endometrial tissue. Methods for diagnosing endometrial receptivity and bleeding function by screening a biological sample such as an endometrial tissue sample, or bodily fluid for the presence of ebaf. A contraceptive compound containing an effective amount of ebaf and a pharmaceutically acceptable carrier. A diagnostic kit for timing contraception containing reagents for screening a sample for the presence of ebaf. A method of treating endometrial irregularities by down-regulating the expression of ebaf. | 08-21-2008 |
20100227811 | FARNESYLAMINE DERIVATIVES AND METHODS OF USE - The present invention concerns farnesylamine derivatives, compositions containing these compounds, and methods of using these compounds and compositions as inhibitors of ras-mediated signal transduction and inhibitors of aberrant cell growth, e.g., as anti-cancer agents, as well as anti-fungal agents. Other non-malignant diseases characterized by proliferation of cells that may be treated using the farneylamine derivatives of the include, but are not limited to, cirrhosis of the liver; graft rejection; restenosis; and disorders characterized by a proliferation of T cells such as autoimmune diseases, e.g., type 1 diabetes, lupus and multiple sclerosis. | 09-09-2010 |
20100292451 | METHOD FOR DIAGNOSING SELECTED ADENOCARCINOMAS - A method for the early diagnosing of selected adenocarcinomas in a human comprising the steps of removing a bodily sample from the human, and assaying the bodily sample for elevated expression of a specific gene. The gene being assayed for in the bodily sample is the TGFB-4 gene (hereinafter referred to as the endometrial bleeding associated factor (ebaf) gene. The bodily sample can be tissue from a specific organ in the body, or a blood sample. Increased levels of ebaf in the sample relative to basal levels may be indicative of a mucinous adenocarcinoma of the colon or ovaries, or an adenocarcinoma of the testis. | 11-18-2010 |
20120149017 | DIAGNOSTIC MARKERS OF HUMAN FEMALE INFERTILITY - The subject invention pertains to methods and reagents for the diagnosis of female infertility, prognostic indicators for female infertility, compounds for the treatment of female infertility, compounds and methods for contraception. Methods and compounds are based on the levels of ebaf in endometrial tissue. Methods for diagnosing endometrial receptivity and bleeding function by screening a biological sample such as an endometrial tissue sample, or bodily fluid for the presence of ebaf. A contraceptive compound containing an effective amount of ebaf and a pharmaceutically acceptable carrier. A diagnostic kit for timing contraception containing reagents for screening a sample for the presence of ebaf. A method of treating endometrial irregularities by down-regulating the expression of ebaf. | 06-14-2012 |
Sesha Durga Kumar Kothapalli, Ithaca, NY US
Patent application number | Description | Published |
---|---|---|
20150018378 | FADS REGULATION - The present invention relates methods to increase the expression of fatty acid desaturases (FADS) and increase cellular and tissue levels of highly unsaturated fatty acids (HUFA) by modulating one or more of the FADS via the action of specific classes of drugs (e.g., statins and LXR agonists). The present invention also relates to methods of treating conditions (e.g., tumor and cancer) involving deficient function of FADS by administering statins and/or LXR agonists. The present invention further relates to methods of determining the need for statins or dietary LCPUFA in subjects. | 01-15-2015 |
Shardul Kothapalli, Chandler, AZ US
Patent application number | Description | Published |
---|---|---|
20140115723 | System and Method for Digital Media Distribution - The present invention comprises a digital media delivery system with a physical authorization device for downloading media files to a digital media player. The physical authorization device is most preferably an indicia-bearing card, containing at least one of an NFC circuit with the NFC circuit comprising a reusable media authorization code, and/or a Quick Response code with a reusable media authorization code embedded in the QR code, and/or an eye-legible version of the reusable media authorization code. By touching or tapping the indicia-bearing card on the NFC enabled media player, or scanning the QR code, or entering the eye-legible media authorization code from the authorization device into a digital media player, the reusable media authorization code is transmitted to a file server on the Internet via an application on the digital media player and one or more media files will be downloaded to the digital media player or otherwise enabled for accessing on the digital media player. Once downloaded to the digital media player or otherwise enabled, the user may access the downloaded media file(s). | 04-24-2014 |
Sri R. Kothapalli, St. Louis, MO US
Patent application number | Description | Published |
---|---|---|
20100245694 | Systems and Methods of All-Optical Fourier Phase Contrast Imaging Using Dye Doped Liquid Crystals - An assembly for converting a microscope into a phase contrast microscope includes a first optical Fourier element that Fourier transforms light from a coherent light source, a cell in the Fourier plane arranged to receive light from the first optical Fourier element, a second optical Fourier element arranged to receive light from the cell and inversely Fourier transform the received light to provide an image, an image sensor that detects the image and generates an electronic representation of the image, and an adaptor capable of coupling the first and second Fourier elements, the cell, and the image sensor to the microscope such that the first Fourier element Fourier transforms light collected by the microscope objective. The cell includes liquid crystal molecules having a phase transition temperature, wherein at temperatures exceeding the phase transition temperature, light transmitting through the liquid crystal molecules obtains a different phase than light transmitting through the liquid crystal molecules at temperatures below the phase transition temperature. | 09-30-2010 |
Sri-Rajasekhar Kothapalli, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20120220870 | OPTICAL IMAGING PROBES, OPTICAL IMAGING SYSTEMS, METHODS OF OPTICAL IMAGING, AND METHODS OF USING OPTICAL IMAGING PROBES - Embodiments of the present disclosure provide for radionuclide probes, methods of using the radionuclide probes, methods of detecting an optical signal from radionuclides, methods of detecting an optical signal from a quantum dot(s) that receives optical energy from a radionuclide(s), system for analyzing optical energy emitted by a radionuclide(s), system for imaging a target within a living subject or a sample, methods of imaging a disease or condition, and the like. | 08-30-2012 |